1 study found for:    21041705 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting A Pilot Study of Alemtuzumab (Campath[R]) in Patients With Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Intervention: Drug: Alemtuzumab (Campath)

Indicates status has not been verified in more than two years